Esperion Therapeutics | ESPR - Ordinary Share Capital


Esperion Therapeutics reported $245.22M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amarin USD 20.81M 13K Dec/2025
Amgen USD 540M 1000K Mar/2026
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Cipla INR 807.78M 17K Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 124.43M 2.17M Mar/2026
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Geron USD 640.9M 2.54M Mar/2026
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 118.52M 741K Mar/2026
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
Merck USD 2.47B 12.72M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Pfizer USD 5.7B 13M Mar/2026
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Sarepta Therapeutics USD 105.57M 607K Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Vanda Pharmaceuticals USD 58K 0 Dec/2024